If you’re an athlete, joint pain is more than just an inconvenience—it’s an obstacle that can limit your performance and slow your progress. Whether it’s the result of intense training or the natural wear and tear on your body, joint pain can become a constant companion for those pushing their physical limits.
While many athletes turn to painkillers like NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) or supplements like glucosamine, these options only offer temporary relief and can come with unwanted side effects.
Enter Kre-Celazine®, a patented (#9,968,581) revolutionary, natural solution designed to alleviate joint pain and enhance athletic performance. Kre-Celazine® is more than just another joint supplement—it’s a scientifically backed, patented formula that addresses the root cause of inflammation while supporting muscle recovery, strength, and overall mobility.
Joint pain is often the result of chronic inflammation, a natural response your body has to injury, overuse, or intense exercise. While acute inflammation is your body’s way of healing, chronic inflammation can cause lasting damage to your joints and muscles. Over time, this can lead to conditions like arthritis, reduced flexibility, and decreased athletic performance. Athletes and fitness enthusiasts, in particular, face this problem head-on as they continuously push their bodies to the limit.
While NSAIDs may offer temporary relief, they can lead to dangerous side effects like gastrointestinal damage, liver problems, and kidney failure when used long-term.5 Glucosamine, another popular choice, may help with symptoms but doesn’t address the root cause: inflammation. On top of that, glucosamine has been shown to raise blood sugar levels when taken in high doses, which can be problematic for some athletes.1,2,3
Kre-Celazine® takes an entirely different approach. This patented compound has been clinically proven to reduce joint pain and inflammation while promoting flexibility and mobility.4,5 What sets Kre-Celazine® apart from other joint supplements is its unique combination of esterified fatty acids and Kre-Alkalyn®, a pH-balanced form of creatine. Together, these ingredients work to not only relieve pain but also enhance your overall athletic performance.6,7,8
But it doesn’t stop there—Kre-Celazine® has even received orphan drug status, a prestigious designation granted by the FDA for compounds that show promise in treating rare conditions. This status underscores the uniqueness and effectiveness of Kre-Celazine® in addressing inflammation and pain, making it stand out in the crowded joint health market.
Kre-Celazine® combines the joint-relieving power of esterified fatty acids with the performance-boosting benefits of Kre-Alkalyn® to deliver a powerful 2-in-1 solution for athletes.
Kre-Celazine® isn’t just a joint supplement—it’s a complete system that enhances joint health, muscle recovery, and athletic performance. Here’s what athletes can expect from this breakthrough formula:
Receiving orphan drug status from the FDA is no small feat. This designation is granted to compounds that show promise in treating rare diseases or conditions and provides them with special support during the development and approval process. For Kre-Celazine®, this recognition highlights its potential to reduce joint pain and help manage conditions related to chronic inflammation.
While it is still undergoing the New Dietary Ingredient (NDI) process, this FDA designation underscores the groundbreaking nature of Kre-Celazine® and its potential to revolutionize how athletes manage joint pain and inflammation.
What makes Kre-Celazine® stand out is its ability to do more than relieve pain—it actively enhances your performance. With its combination of esterified fatty acids for joint relief and Kre-Alkalyn® for muscle energy and recovery, you’re getting a complete system supporting your joints and athletic potential.9,10
If joint pain is holding you back, Kre-Celazine® is the answer. Its patented formula addresses inflammation and pain at the source and boosts your performance by replenishing muscle energy and maintaining pH balance. With clinical studies backing its effectiveness and its designation as an orphan drug, Kre-Celazine® is a groundbreaking solution for athletes who want to train harder, recover faster, and stay pain-free. It’s the active ingredient in products such as Joint Rehab by EFX Sports.
It’s time to ditch the temporary fixes and embrace a complete, natural solution supporting your body’s healing processes while enhancing your athletic abilities. Kre-Celazine® is here to help you reach your full potential.
In-Text References
General References
Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006; 8(4):R127. And at www.arthritis-research.com/con- tent/8/4/R127 Pages 1-22. [Accessed on 10-1-2008]
Ameye LG, Young MF. Animal models of osteoarthritis: lessons learned while seeking the “Holy Grail.“ Curr Opin Rheumatol. 2006; 18(5):537-547.
Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2008; 16(4):399-408.
Golini, J. (2007, August 20). An Acute Oral Toxicity Study in Rats with Kre-Celazine. BioCeutical Research & Development Laboratory. BRDL Study.
Golini, J. (2008, January 27). Trial using Kre-Celazine for Pain. BioCeuticals Research & Development Laboratory. BRDL Study No. 1252.
Golini, J., & Jones, W. L. (2014). Kre-Celazine as a viable treatment for juvenile rheumatoid arthritis/juvenile idiopathic arthritis – A pilot study. Journal of Medicinal Food, 17(9), 1022-1026. doi:10.1089/jmf.2013.016
Henrotin Y. Avocado/soybean unsaponifiable (ASU) to treat osteoarthritis: a clarification. Osteoarthritis Cartilage. 2008; 16(9):1118-1119.
Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001; (1): CD002947.
Nomura A, Zhang M, Sakamoto T, et al. Anti-inflammatory activity of creatine supplementation in endothelial cells in vitro. Br J Pharmacol. 2003; 139(4):715- 720.
Momekov, G. T., & Atanassova, T. (2007, August 25). Investigation Report on Project Kre-Celazine®: Antiproliferative effects of creatine mixed/bonded to fats B non-stabilized or buffered in a panel of human tumor cell lines. Medical University B Sofia, Faculty of Pharmacy, Department of Pharmacology, Pharmacotherapy and Toxicology, Lab of Experimental Chemotherapy and Molecular Pharmacology.